{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:17:57Z","timestamp":1771971477072,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11047-6","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:58:23Z","timestamp":1746187103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic dilemma of a new endobronchial lesion in a patient on anti-tuberculosis regimen: unveiling tuberculosis immune reconstitution inflammatory syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Ming Ren","family":"Toh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie Seine Xuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takano","family":"Angela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thun How","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"1","key":"11047_CR1","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"key":"11047_CR2","doi-asserted-by":"crossref","unstructured":"Wallis RS. Reactivation of latent tuberculosis by TNF Blockade: the role of interferon \u03b3. J Invest Dermatology Symp Proc. 2007;12(1):16\u201321.","DOI":"10.1038\/sj.jidsymp.5650031"},{"key":"11047_CR3","doi-asserted-by":"crossref","unstructured":"Kasiraman V, Atwan AA, Durojaiye OC, Kalavala M, Piguet V. Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management. Dermatol Online J. 2014;20(8).","DOI":"10.5070\/D3208023525"},{"issue":"6","key":"11047_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2217\/fmb.15.9","volume":"10","author":"PE Namale","year":"2015","unstructured":"Namale PE, Abdullahi LH, Fine S, Kamkuemah M, Wilkinson RJ, Meintjes G. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and Meta-analysis. Future Microbiol. 2015;10(6):1077\u201399.","journal-title":"Future Microbiol"},{"issue":"1","key":"11047_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1346-8138.14074","volume":"45","author":"H Sueki","year":"2018","unstructured":"Sueki H, Mizukawa Y, Aoyama Y. Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients. J Dermatol. 2018;45(1):3\u20139.","journal-title":"J Dermatol"},{"issue":"1","key":"11047_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.resinv.2019.11.001","volume":"58","author":"J Fujita","year":"2020","unstructured":"Fujita J. Immune reconstitution inflammatory syndrome in the lung in non-human immunodeficiency virus patients. Respiratory Invest. 2020;58(1):36\u201344.","journal-title":"Respiratory Invest"},{"key":"11047_CR7","doi-asserted-by":"crossref","unstructured":"Ang ML, Teng CSM, Yiang CLT-ECH, Lip CK, Maciej CP, Li H, Yang DO, Balasubramaniam. Sng Li Hwei, Tan Jamie Bee Xian, Tan Cher Heng, Tay Jun Yang, Teo Lynette Li San, Thoon Koh Cheng, Yan Gabriel Zherong. Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease. Annals Acad Med Singapore. 2024;53(3):170\u2013\u200986.","DOI":"10.47102\/annals-acadmedsg.2023391"},{"issue":"5","key":"11047_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","volume":"79","author":"G Sotgiu","year":"2019","unstructured":"Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, et al. QuantiFERON TB gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019;79(5):444\u201353.","journal-title":"J Infect"},{"issue":"12","key":"11047_CR9","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","volume":"171","author":"S Verver","year":"2005","unstructured":"Verver S, Warren RM, Beyers N, Richardson M, Spuy GDvd, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171(12):1430\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"11047_CR10","unstructured":"Prevention, ECfD. Control. Programmatic management of latent tuberculosis infection in the European union. ECDC Stockholm; 2018."},{"issue":"2","key":"11047_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American thoracic society\/infectious diseases society of America\/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111\u20135.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"11047_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM. Interferon-\u03b3 assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4(12):761\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"11047_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.47102\/annals-acadmedsg.2023391","volume":"53","author":"MLT Ang","year":"2024","unstructured":"Ang MLT, Chan SM, Cheng LT-E, Cheong HY, Chew KL, Chlebicki PM, et al. Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease. Ann Acad Med Singapore. 2024;53(3):170\u201386.","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"11047_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/09546634.2015.1115815","volume":"27","author":"MG Johnson","year":"2016","unstructured":"Johnson MG, Bialas RW, Hall RP, Stout JE. Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay? J Dermatolog Treat. 2016;27(4):378\u201380.","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"11047_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1513\/AnnalsATS.201508-532OC","volume":"13","author":"TE Gamsky","year":"2016","unstructured":"Gamsky TE, Lum T, Hung-Fan M, Green JA. Cumulative False-Positive QuantiFERON-TB Interferon-\u03b3 release assay results. Annals Am Thorac Soc. 2016;13(5):660\u20135.","journal-title":"Annals Am Thorac Soc"},{"key":"11047_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2334-9-23","volume":"9","author":"S Ribeiro","year":"2009","unstructured":"Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, Chaisson RE, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009;9:23.","journal-title":"BMC Infect Dis"},{"key":"11047_CR17","doi-asserted-by":"crossref","unstructured":"Chee CBE, Khinmar KW, Gan SH, Barkham TM, Koh CK, Shen L et al. Tuberculosis treatment effect on T-cell interferon-\u03b3 responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2010;36(2):355\u201361.","DOI":"10.1183\/09031936.00151309"},{"issue":"4","key":"11047_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1086\/596606","volume":"30","author":"NR Pollock","year":"2009","unstructured":"Pollock NR, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, et al. Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol. 2009;30(4):392\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"11047_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","volume":"71","author":"SH Wong","year":"2016","unstructured":"Wong SH, Gao Q, Tsoi KKF, Wu WKK, Tam L-s, Lee N, et al. Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax. 2016;71(1):64\u201372.","journal-title":"Thorax"},{"issue":"10","key":"11047_CR20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"BTS recommendations for assessing risk","year":"2005","unstructured":"BTS recommendations for assessing risk. For managing\u2009<\u2009em\u2009>\u2009mycobacterium tuberculosis\u2009infection and disease in patients due to start anti-TNF-\u03b1 treatment. Thorax. 2005;60(10):800\u20135.","journal-title":"Thorax"},{"issue":"4","key":"11047_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40257-019-00432-y","volume":"20","author":"I Snast","year":"2019","unstructured":"Snast I, Bercovici E, Solomon-Cohen E, Avni T, Shitenberg D, Hodak E, et al. Active tuberculosis in patients with psoriasis receiving biologic therapy: A systematic review. Am J Clin Dermatol. 2019;20(4):483\u201391.","journal-title":"Am J Clin Dermatol"},{"issue":"17","key":"11047_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.2023.3954","volume":"329","author":"DE Jonas","year":"2023","unstructured":"Jonas DE, Riley SR, Lee LC, Coffey CP, Wang S-H, Asher GN, et al. Screening for latent tuberculosis infection in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2023;329(17):1495\u2013509.","journal-title":"JAMA"},{"issue":"5","key":"11047_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1513\/AnnalsATS.201701-055ED","volume":"14","author":"H Esmail","year":"2017","unstructured":"Esmail H, Wilkinson RJ. Minimizing tuberculosis risk in patients receiving Anti-TNF therapy. Annals Am Thorac Soc. 2017;14(5):621\u20133.","journal-title":"Annals Am Thorac Soc"},{"issue":"4","key":"11047_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40257-022-00679-y","volume":"23","author":"M Masson Regnault","year":"2022","unstructured":"Masson Regnault M, Shourick J, Jendoubi F, Tauber M, Paul C. Time to relapse after discontinuing systemic treatment for psoriasis: A systematic review. Am J Clin Dermatol. 2022;23(4):433\u201347.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"11047_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2006.01.002","volume":"53","author":"W Manosuthi","year":"2006","unstructured":"Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect. 2006;53(6):357\u201363.","journal-title":"J Infect"},{"issue":"12","key":"11047_CR26","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.3390\/diagnostics12122985","volume":"12","author":"HM Saad","year":"2022","unstructured":"Saad HM, Tourky GF, Al-Kuraishy HM, Al-Gareeb AI, Khattab AM, Elmasry SA, et al. The potential role of MUC16 (CA125) biomarker in lung cancer: a magic biomarker but with adversity. Diagnostics. 2022;12(12):2985.","journal-title":"Diagnostics"},{"key":"11047_CR27","doi-asserted-by":"crossref","unstructured":"Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV et al. Tuberculosis IRIS: pathogenesis, presentation, and management across the spectrum of disease. Life (Basel). 2020;10(11).","DOI":"10.3390\/life10110262"},{"issue":"20","key":"11047_CR28","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa1800762","volume":"379","author":"G Meintjes","year":"2018","unstructured":"Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, et al. Prednisone for the prevention of Paradoxical Tuberculosis-Associated IRIS. N Engl J Med. 2018;379(20):1915\u201325.","journal-title":"N Engl J Med"},{"issue":"4","key":"11047_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10096-023-04564-2","volume":"42","author":"L Armange","year":"2023","unstructured":"Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-\u03b1 antagonists in tuberculosis to control severe Paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur J Clin Microbiol Infect Dis. 2023;42(4):413\u201322.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11047-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:58:29Z","timestamp":1746187109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11047"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11047-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SingHealth Centralised Institutional Review Board (CIRB) review was not required for case report of one to two patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"648"}}